Delivery Order SPE2DB24D1021-SPE2DB25FEZUC
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,323.52 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 mL syringes on July 23, 2025, with completion expected by August 13, 2025. This is a firm fixed-price delivery order issued under a competitively awarded indefinite delivery contract. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award reflects no set-aside designation, indicating it...
- The Defense Logistics Agency awarded a $3,580.88 delivery order to AmerisourceBergen Drug Corp for Kineret (anakinra) 100 mg/0.67 mL syringes on August 14, 2025, with a completion date of September 5, 2025. This firm fixed-price contract, which carries no set-aside designation, reflects a competitive award to the pharmaceutical distributor for delivery to its corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Kineret 100 mg/0.67 mL syringes, with a ceiling value of $11,637.86 and firm fixed pricing. This delivery order, which is not set-aside designated, represents a competitive award under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $2,685.66 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 ml syringes. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure. Performance will be completed by August 28, 2025, with the contract issued on August 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $30,970.59 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Kineret 100 mg/0.67 ml syringes. This non-set-aside, firm fixed price delivery order is scheduled for completion by August 8, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Kineret (anakinra) is a recombinant interleukin-1 receptor antagonist used primarily for treating rheumatoid arthritis and...
- This is a $7,161.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of KINERET 100 MG/0.67 ML SYRINGE 0.67ML medical products, with a period of performance through April 9, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,371.32 firm fixed-price delivery order is for the provision of Kineret 100 mg/0.67 ml syringes. The contract has a period of performance through July 17, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Kineret 100 mg/0.67 ml syringes. The fixed-price contract, valued at $4,476.10, has an ultimate completion date of April 8, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a...
- The Defense Logistics Agency awarded a $3,967.70 delivery order to Amerisourcebergen Drug Corporation for Kineret 100 mg/0.67 ml syringes. The firm fixed price order is for the delivery of pharmaceutical products to a location in Conshohocken, Pennsylvania, and has a period of performance from August 24, 2023 through September 15, 2023. As a major supplier of medical materiel to the U.S. Department of Defense, the Defense Logistics Agency utilizes contracts such as Amerisourcebergen's...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Kineret 100 mg/0.67 mL syringes, a medication used to treat certain autoimmune disorders. The contract has a ceiling value of $7,161.76 and a period of performance through May 28, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEZUCDelivery Order
The Defense Logistics Agency awarded a $3,580.88 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Kineret 100 mg/0.67 mL syringes. This non-set-aside contract is scheduled for completion by September 9, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, will fulfill this delivery order through its existing Indefinite Delivery Contract (IDC) relationship with DLA Troop Support Medical. This delivery order represents a routine procurement under AmerisourceBergen Drug Corp's substantial $999.999 billion IDC with the Defense Logistics Agency, designated as SPE2DX and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Kineret, a biologic medication used to treat rheumatoid arthritis and other inflammatory conditions, is among the specialized pharmaceutical products routinely procured through this contract vehicle for military healthcare beneficiaries and systems. The contractor's award reflects its demonstrated capability to meet federal procurement requirements through open competition and its established role as a primary supplier within the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 8/18/25 |